NIKKEI 225
28,546.18-276.11(-0.96%)HANG SENG
29,421.13-737.88(-2.45%)CRUDE OIL
52.37-0.40(-0.76%)
Velocys plc (VLS.L)
| Previous close | 6.92 |
| Open | 7.00 |
| Bid | 7.52 x 0 |
| Ask | 7.68 x 0 |
| Day's range | 6.98 - 7.86 |
| 52-week range | 1.50 - 16.64 |
| Volume | 5,119,908 |
| Avg. volume | 7,089,446 |
| Market cap | 81.94M |
| Beta (5Y monthly) | 1.37 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.30 |
| Earnings date | 17 Sep 2020 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 26.65 |
- The Guardian
Shell pulls out of joint venture to build UK sustainable jet fuels plant
Shell pulls out of joint venture to build UK sustainable jet fuels plantWithdrawal a blow to Boris Johnson’s desire for UK to achieve first zero-emission long-haul flight
- Business Wire
Fuse Medical, Inc. Enters Into Marketing Agreement With CarePICS Telehealth
Fuse Medical, Inc. (OTCPINK: FZMD) ("Fuse" or the "Company") an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced today an agreement with CarePICS, the latest resource addition to Fuse’s comprehensive portfolio and biologics product offerings for wound care.
- Business Wire
Fuse Medical, Inc. Announces Launch of FuseChoiceTM Biologics Portfolio
Fuse Medical, Inc. (OTCPINK: FZMD) ("Fuse" or the "Company"), an emerging manufacturer and distributor of innovative medical devices for the orthopedic and spine marketplace, announced the initial launch of FuseChoiceTM and FuseChoiceTM Plus Amniotic & Umbilical Membranes, and FuseChoiceTM Plus Amniotic Joint Cushioning Fluid, the latest additions to a comprehensive line of biologics product offerings.
